Cargando…

Human Papillomavirus Infections in Cervical Samples From HIV-Positive Women: Evaluation of the Presence of the Nonavalent HPV Genotypes and Genetic Diversity

Non-nonavalent vaccine (9v) Human papillomavirus (HPV) types have been shown to have high prevalence among HIV-positive women. Here, 1444 cervical samples were tested for HPV DNA positivity. Co-infections of the 9v HPV types with other HPV types were evaluated. The HPV81 L1 and L2 genes were used to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sias, Catia, Guarrasi, Valerio, Minosse, Claudia, Lapa, Daniele, Nonno, Franca Del, Capobianchi, Maria Rosaria, Garbuglia, Anna Rosa, Del Porto, Paola, Paci, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723855/ https://www.ncbi.nlm.nih.gov/pubmed/33324386 http://dx.doi.org/10.3389/fmicb.2020.603657

Ejemplares similares

Alpha, Beta, gamma human PapillomaViruses (HPV) detection with a different sets of primers in oropharyngeal swabs, anal and cervical samples
por: Sias, Catia, et al.
Publicado: (2019)

The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease
por: Garbuglia, Anna Rosa, et al.
Publicado: (2020)

Oral human Papillomavirus DNA detection in HIV-positive men: prevalence, predictors, and co-occurrence at anal site
por: Vergori, Alessandra, et al.
Publicado: (2018)

Hepatitis C Virus Genetic Variability, Human Immune Response, and Genome Polymorphisms: Which Is the Interplay?
por: Lapa, Daniele, et al.
Publicado: (2019)

Clinical Relevance of Torque Teno Virus (TTV) in HIV/HCV Coinfected and HCV Monoinfected Patients Treated with Direct-Acting Antiviral Therapy
por: Lapa, Daniele, et al.
Publicado: (2021)

mRNA- and Adenovirus-Based Vaccines against SARS-CoV-2 in HIV-Positive People
por: Garbuglia, Anna Rosa, et al.
Publicado: (2022)

Sensitivity of Human Papillomavirus (HPV) Lineage and Sublineage Variant Pseudoviruses to Neutralization by Nonavalent Vaccine Antibodies
por: Godi, Anna, et al.
Publicado: (2019)

Single-dose nonavalent HPV vaccine: Need of the hour
por: Pal, Manidip, et al.
Publicado: (2020)

Assessing the impact of data-driven limitations on tracing and forecasting the outbreak dynamics of COVID-19
por: Fiscon, Giulia, et al.
Publicado: (2021)

Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus
por: Toh, Zheng Quan, et al.
Publicado: (2019)

Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, Spain
por: Perez, S., et al.
Publicado: (2017)

Clinical Characteristics of Acute Hepatitis E and Their Correlation with HEV Genotype 3 Subtypes in Italy
por: Minosse, Claudia, et al.
Publicado: (2020)

Anti-HEV IgG Avidity Testing: Utility for Diagnosing Acute and Resolved Genotype 3 Infections
por: Minosse, Claudia, et al.
Publicado: (2021)

Correction to: Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, Spain
por: Perez, S., et al.
Publicado: (2018)

Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France
por: Riethmuller, Didier, et al.
Publicado: (2015)

Nonavalent human papillomavirus vaccination as a treatment for warts in an immunosuppressed adult
por: Ferguson, Sara B., et al.
Publicado: (2017)

Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa
por: Michaeli, Daniel Tobias, et al.
Publicado: (2022)

Potential impact of a nonavalent anti HPV vaccine in Italian men with and without clinical manifestations
por: Bosco, Liana, et al.
Publicado: (2021)

The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?
por: Patel, Cyra, et al.
Publicado: (2018)

Molecular Characterization of HEV Genotype 3 in Italy at Human/Animal Interface
por: De Sabato, Luca, et al.
Publicado: (2020)

Childhood erythrodermic lichen planus pemphigoides after nonavalent human papillomavirus vaccination
por: Pizzatti, Laura, et al.
Publicado: (2020)

Age-Related Changes in the Fraction of Cervical Intraepithelial Neoplasia Grade 3 Related to HPV Genotypes Included in the Nonavalent Vaccine
por: Giannella, Luca, et al.
Publicado: (2019)

Epidemiology of Hepatitis E Virus in European Countries
por: Lapa, Daniele, et al.
Publicado: (2015)

Origin of HAV strains responsible for 2016–2017 outbreak among MSM: Viral phylodynamics in Lazio region
por: Minosse, Claudia, et al.
Publicado: (2020)

Head-to-Head Comparison of Bi- and Nonavalent Human Papillomavirus Vaccine-Induced Antibody Responses( )
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2022)

Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccine
por: Petry, Karl-Ulrich, et al.
Publicado: (2018)

Estimating the epidemiological impact and cost-effectiveness profile of a nonavalent HPV vaccine in Spain
por: De La Fuente, Jesús, et al.
Publicado: (2019)

Taking stock and looking ahead: Behavioural science lessons for implementing the nonavalent human papillomavirus vaccine
por: Forster, Alice S., et al.
Publicado: (2016)

Ultrasensitive HCV RNA Quantification in Antiviral Triple Therapy: New Insight on Viral Clearance Dynamics and Treatment Outcome Predictors
por: Garbuglia, Anna Rosa, et al.
Publicado: (2016)

Nonavalent Human Papillomavirus Vaccination as a Treatment for Skin Warts in Immunosuppressed Adults: A Case Series
por: BOSSART, Simon, et al.
Publicado: (2020)

Simultaneously characterizing the comparative economics of routine female adolescent nonavalent human papillomavirus (HPV) vaccination and assortativity of sexual mixing in Hong Kong Chinese: a modeling analysis
por: Choi, Horace C. W., et al.
Publicado: (2018)

Epidemiology of HEV in the Mediterranean basin: 10-year prevalence in Italy
por: Lanini, Simone, et al.
Publicado: (2015)

Clinical and virological properties of hepatitis C virus genotype 4 infection in patients treated with different direct-acting antiviral agents
por: Minosse, Claudia, et al.
Publicado: (2018)

Ultra-Deep Sequencing Characterization of HCV Samples with Equivocal Typing Results Determined with a Commercial Assay
por: Minosse, Claudia, et al.
Publicado: (2016)

Potential impact of a nonavalent HPV vaccine on HPV related low-and high-grade cervical intraepithelial lesions: A referral hospital-based study in Sicily
por: Capra, Giuseppina, et al.
Publicado: (2017)

Hepatitis E Outbreak in the Central Part of Italy Sustained by Multiple HEV Genotype 3 Strains, June–December 2019
por: Garbuglia, Anna Rosa, et al.
Publicado: (2021)

Detection and genotyping of human papillomavirus (HPV) in HIV-infected women and its relationship with HPV/HIV co-infection
por: Badial, Rodolfo Miglioli, et al.
Publicado: (2018)

Characterization of Novel Cutaneous Human Papillomavirus Genotypes HPV-150 and HPV-151
por: Kovanda, Anja, et al.
Publicado: (2011)

Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis
por: Nardacci, Roberta, et al.
Publicado: (2021)

Phylogenetic and Phylodynamic Analyses of HCV Strains Circulating among Patients Using Injectable Drugs in Central Italy
por: Minosse, Claudia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a7vq9c2ljpoh6ra5j7059ja6b9